@article{0b5340cbfcee43cdbfe19b64b96394f7,
title = "A Novel Calcitriol-producing, Gut-homing CD11b+Gr-1+ Macrophage Specifically Homes to the Inflamed Gut and Robustly Suppresses an Immune-mediated Experimental Colitis: 706",
author = "Yi Xu and Yanmei Cheng and Huynh Cao and David Baylink and Gati Goel and Xiaolei Tang",
note = "Abstracts: ACCEPTED: INFLAMMATORY BOWEL DISEASE Author Information Loma Linda University Medical Center, Loma Linda, CA. Introduction: Inflammatory bowel disease (IBD) is an incurable chronic disease that affects approximately 1.4 million Americans. We recently reported that intravenous delivery of CD11b+Gr-1+ macrophages (CG-MAC) engineered for producing 1,25[OH]2D (VD3) effectively improved mucosal repair and local inflammation control in an intestine injury IBD model, DSS-induced colitis.",
year = "2016",
month = oct,
day = "1",
doi = "10.14309/00000434-201610001-00706",
language = "American English",
volume = "111",
pages = "S318--S319",
journal = "The American Journal of Gastroenterology",
number = "supplement 1",
}